Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virogenetics
Sofia, Bulgaria
- Ownership
- Private
- Development stage
- Other
01
Overview
The company completed initial toxicity studies and advanced towards pharmacokinetic studies and pilot trials for ITV-1 targeting HIV and diabetes; initial feedback on immune system benefit has been positive, with international interest and regulatory engagement underway
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesGastroenterologyNeurology
- Modalities
- ProteinMonoclonal antibodyImmunotherapyNutraceutical
- Industry
- Biotech
02
Partnerships
Bulgarian National Centre for EndocrinologyVetProm-Danson manufacturing facility (French concern Danson)Korporativ Klinik Drug Research and Development (Germany)Bulgarian Academy of Sciences
Beyond the preview
Go deeper on Virogenetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virogenetics.